Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 57,920,959
- Total 13F value
- $801,022,755
- Share change
- -8,035,569
- Put/Call ratio
- 117%
- SEC-reported price per share
- $13.83
- Number of holders
- 139
- Value change
- -$114,549,555
- Number of buys
- 67
- Number of sells
- 62
- Shares outstanding
- 130,441,060
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
139
Top holders
10
AUPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Ownership snapshot
Top reported holders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HealthCor Management, L.P.
Disclosed value leader
HealthCor Management, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 6.8%
Showing 1-6 of 15 holder rows.
Quick read
HealthCor Management, L.P. leads the comparable SEC ownership view at 6.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HealthCor Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
HealthCor Management, L.P.
6.8%
NEA Management Company, LLC
4%
FMR LLC
3.7%
ORBIMED ADVISORS LLC
3.6%
PICTET ASSET MANAGEMENT LTD
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HealthCor Management, L.P. |
13F
Company
|
6.8%
|
$130,713,000
8,873,953 shares
|
— | 30 Sep 2020 |
| NEA Management Company, LLC |
13F
Company
|
4%
|
$76,194,000
5,172,683 shares
|
— | 30 Sep 2020 |
| FMR LLC |
13F
Company
|
3.7%
|
$71,922,000
4,882,654 shares
|
— | 30 Sep 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3.6%
|
$70,026,000
4,754,000 shares
|
— | 30 Sep 2020 |
| PICTET ASSET MANAGEMENT LTD |
13F
Company
|
2.9%
|
$55,336,000
3,756,656 shares
|
— | 30 Sep 2020 |
| Avidity Partners Management LP |
13F
Company
|
2.7%
|
$52,511,000
3,564,900 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
139
Shares
57,920,959
Rows available
139
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
144
Q4 2020 holders
139
Holder diff
-5
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend